JDRF welcomes Disability Advisory Committee's recommendation that all Canadians needing life-sustaining therapy should automatically meet the criteria for the Disability Tax Credit and urges the Government to adopt this approach
JDRF Canada, the leading global funder of type 1 diabetes (T1D) research, welcomes the release of the Disability Advisory Committee’s (DAC) Firs...Read More
Montreal Canadiens star and JDRF National Spokesperson Max Domi joins Montreal-area kids living with type 1 diabetes May 28 for a frank discussion on the disease
Hosted from the Windsor Ballrooms in Montreal, the unique conversation features 13 young Canadians interviewing Domi on his experiences with T1D and upcoming participating in the Sun Life Walk to Cure Diabetes for JDRF
Boston Pizza is advancing the academic goals of young people through two new initiatives in support of JDRF
Boston Pizza Foundation Future Prospects is committed to helping youth be the best they can be and has partnered with JDRF to improve the lives of those living with type 1 diabetes (T1D) – an autoimmune disease that affects 300,000 Canadians.
JDRF International Board Appoints Leading Diabetes Researcher and Advocate Aaron J. Kowalski, Ph.D. as New President & CEO
Internationally recognized diabetes expert, first JDRF CEO with T1D will lead next phase of focused effort to end type 1 diabetes
Sun Life deepens commitment to fight type 1 diabetes in Canada with title sponsorship of JDRF signature fundraising event, the Sun Life Ride to Defeat Diabetes for JDRF
Sponsorship enables increased awareness of type 1 diabetes and investment in research, building upon Sun Life’s global commitment toward type 1 and type 2 diabetes
JDRF Canada is extremely pleased with the House of Commons Standing Committee on Health Report on a Diabetes Strategy for Canada
OTTAWA, ON – (April 10, 2019) -- JDRF is very pleased with the 11 recommendations made today by the House of Commons Standing Committee on Health in their report: A Diabetes Strategy for Canada, in alignment with the organization’s recommendations included in their 20...
JDRF Canada is pleased to announce the appointment of Dr. Sarah Linklater as Chief Scientific Officer (CSO). Sarah has over a decade of extensive experience as a professional scientific editor, with a focus on clinical diabetes and endocrinology, basic immunology and other areas of the life sciences...
JDRF welcomes Government's decision to end RDSP clawbacks when DTC status lost, but says opportunity missed to support Canadians with diabetes through a national diabetes strategy
JDRF Canada, the leading global funder of type 1 diabetes research, welcomed the news in this year’s federal budget that the government intends to end the practice of clawing back contributions to Registered Disability Savings Plans (RDSPs) for those whose eligibility status for the Disab...
Two pioneering Canadian investigators pursuing careers in type 1 diabetes research have each been awarded a post-doctoral fellowship ($60,000 CAD), thanks to a longstanding partnership between Eli Lilly Canada Inc. (Lilly Canada) and JDRF Canada.
JDRF Canada welcomes Senate report on "Breaking Down Barriers" for Canadians with Disabilities in accessing the Disability Tax Credit and Registered Disability Savings Plan
JDRF Canada welcomes a report released today by the Senate Standing Committee on Social Affairs, Science and Technology entitled: “Breaking Down Barriers, a critical analysis of the Disability Tax Credit and the Registered Disability Savings Plan”.